Literature DB >> 22058290

The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita.

Xi-Lei Zeng1, Naresh R Thumati, Helen B Fleisig, Kyle R Hukezalie, Sharon A Savage, Neelam Giri, Blanche P Alter, Judy M Y Wong.   

Abstract

X-linked dyskeratosis congenita (X-DC) is caused by mutations in the housekeeping nucleolar protein dyskerin. Amino acid changes associated with X-DC are remarkably heterogeneous. Peripheral mononuclear blood cells and fibroblasts isolated from X-DC patients harbor lower steady-state telomerase RNA (TER) levels and shorter telomeres than healthy age-matched controls. Previously, we showed that retroviral expression of recombinant TER, together with expression of recombinant telomerase reverse transcriptase, restored telomere maintenance and proliferative capacity in X-DC patient cells. Using rare X-DC isoforms (ΔL37 and A386T dyskerin), we showed that telomere maintenance defects observed in X-DC are solely due to decreased steady-state levels of TER. Disease-associated reductions in steady-state TER levels cause deficiencies in telomere maintenance. Here, we confirm these findings in other primary X-DC patient cell lines coding for the most common (A353V dyskerin) and more clinically severe (K314R and A353V dyskerin) X-DC isoforms. Using cell lines derived from these patients, we also examined the steady-state levels of other hinge-ACA motif RNAs and did not find differences in their in vivo accumulations. We show, for the first time, that purified telomerase holoenzyme complexes from different X-DC cells have normal catalytic activity. Our data confirm that dyskerin promotes TER stability in vivo, endorsing the development of TER supplementation strategies for the treatment of X-DC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22058290      PMCID: PMC3263989          DOI: 10.1093/hmg/ddr504

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  45 in total

Review 1.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

2.  Subnuclear shuttling of human telomerase induced by transformation and DNA damage.

Authors:  Judy M Y Wong; Leonard Kusdra; Kathleen Collins
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

Review 3.  Dyskeratosis congenita.

Authors:  A Marrone; P J Mason
Journal:  Cell Mol Life Sci       Date:  2003-03       Impact factor: 9.261

4.  Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; June A Peters; Jennifer T Loud; Lisa Leathwood; Ann G Carr; Mark H Greene; Philip S Rosenberg
Journal:  Br J Haematol       Date:  2010-04-30       Impact factor: 6.998

5.  Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice.

Authors:  Jun He; Sandra Navarrete; Murek Jasinski; Tom Vulliamy; Inderjeet Dokal; Monica Bessler; Philip J Mason
Journal:  Oncogene       Date:  2002-10-31       Impact factor: 9.867

Review 6.  Cancer in dyskeratosis congenita.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; Philip S Rosenberg
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

7.  Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita.

Authors:  Judy M Y Wong; Mouhammed J Kyasa; Laura Hutchins; Kathleen Collins
Journal:  Hum Genet       Date:  2004-09-03       Impact factor: 4.132

8.  Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.

Authors:  Tom Vulliamy; Richard Beswick; Michael Kirwan; Anna Marrone; Martin Digweed; Amanda Walne; Inderjeet Dokal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-03       Impact factor: 11.205

9.  Pathogenic NAP57 mutations decrease ribonucleoprotein assembly in dyskeratosis congenita.

Authors:  Petar N Grozdanov; Narcis Fernandez-Fuentes; Andras Fiser; U Thomas Meier
Journal:  Hum Mol Genet       Date:  2009-09-04       Impact factor: 6.150

10.  Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.

Authors:  Luis F Z Batista; Matthew F Pech; Franklin L Zhong; Ha Nam Nguyen; Kathleen T Xie; Arthur J Zaug; Sharon M Crary; Jinkuk Choi; Vittorio Sebastiano; Athena Cherry; Neelam Giri; Marius Wernig; Blanche P Alter; Thomas R Cech; Sharon A Savage; Renee A Reijo Pera; Steven E Artandi
Journal:  Nature       Date:  2011-05-22       Impact factor: 49.962

View more
  14 in total

1.  GSE4 peptide suppresses oxidative and telomere deficiencies in ataxia telangiectasia patient cells.

Authors:  Laura Pintado-Berninches; Beatriz Fernandez-Varas; Carlos Benitez-Buelga; Cristina Manguan-Garcia; Almudena Serrano-Benitez; Laura Iarriccio; Jaime Carrillo; Guillermo Guenechea; Susana P Egusquiaguirre; Jose-Luis Pedraz; Rosa M Hernández; Manoli Igartua; Elena G Arias-Salgado; Felipe Cortés-Ledesma; Leandro Sastre; Rosario Perona
Journal:  Cell Death Differ       Date:  2019-01-22       Impact factor: 15.828

2.  Regulation of human telomerase RNA biogenesis and localization.

Authors:  Jian Qin; Chantal Autexier
Journal:  RNA Biol       Date:  2020-09-02       Impact factor: 4.652

3.  Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations.

Authors:  Jialin Xu; Payal P Khincha; Neelam Giri; Blanche P Alter; Sharon A Savage; Judy M Y Wong
Journal:  Am J Hematol       Date:  2016-11-04       Impact factor: 10.047

4.  Clonal hematopoiesis in patients with dyskeratosis congenita.

Authors:  Nieves Perdigones; Juan C Perin; Irene Schiano; Peter Nicholas; Jaclyn A Biegel; Philip J Mason; Daria V Babushok; Monica Bessler
Journal:  Am J Hematol       Date:  2016-10-21       Impact factor: 10.047

5.  Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domain.

Authors:  Rosario Machado-Pinilla; Jaime Carrillo; Cristina Manguan-Garcia; Leandro Sastre; Alexander Mentzer; B-W Gu; Philip J Mason; Rosario Perona
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

Review 6.  Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder.

Authors:  Galina Glousker; Fabien Touzot; Patrick Revy; Yehuda Tzfati; Sharon A Savage
Journal:  Br J Haematol       Date:  2015-05-04       Impact factor: 6.998

7.  In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs.

Authors:  Kyle R Hukezalie; Naresh R Thumati; Hélène C F Côté; Judy M Y Wong
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

8.  Expression of the genetic suppressor element 24.2 (GSE24.2) decreases DNA damage and oxidative stress in X-linked dyskeratosis congenita cells.

Authors:  Cristina Manguan-Garcia; Laura Pintado-Berninches; Jaime Carrillo; Rosario Machado-Pinilla; Leandro Sastre; Carme Pérez-Quilis; Isabel Esmoris; Amparo Gimeno; Jose Luis García-Giménez; Federico V Pallardó; Rosario Perona
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

9.  Clinical heterogeneity in a family with DKC1 mutation, dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome in first cousins.

Authors:  Cristina Olivieri; Anna Mondino; Matteo Chinello; Alessandra Risso; Enrico Finale; Marina Lanciotti; Andrea Guala
Journal:  Pediatr Rep       Date:  2017-10-06

10.  Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer Treatment.

Authors:  Romina Gabriela Armando; Diego Luis Mengual Gómez; Ezequiel Ivan Juritz; Pablo Lorenzano Menna; Daniel Eduardo Gomez
Journal:  Int J Mol Sci       Date:  2018-10-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.